Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Income (Loss) After Income Taxes
QFR115385USNO • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
32,146.00
Year-over-Year Change
8.60%
Date Range
10/1/2000 - 4/1/2025
Summary
This trend tracks the quarterly net income or loss for U.S. pharmaceutical and medicine corporations after accounting for income taxes. It provides critical insight into the financial performance and profitability of a key sector in the American healthcare and biotechnology industry.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
The metric represents the post-tax earnings of pharmaceutical corporations, reflecting their operational efficiency, research investment, and market competitiveness. Economists and investors use this data to assess the sector's economic health, innovation potential, and overall contribution to national economic output.
Methodology
Data is collected through comprehensive quarterly financial reports submitted by pharmaceutical corporations to regulatory agencies, then aggregated and analyzed by the U.S. Federal Reserve.
Historical Context
This trend is used by policymakers, investors, and economic analysts to evaluate sector performance, potential investment opportunities, and broader healthcare industry dynamics.
Key Facts
- Represents quarterly net income for U.S. pharmaceutical corporations
- Includes post-tax earnings and financial performance metrics
- Critical indicator of healthcare sector economic health
FAQs
Q: What does this economic trend measure?
A: It measures the quarterly net income or loss for U.S. pharmaceutical and medicine corporations after income taxes, providing insight into the sector's financial performance.
Q: Why is this trend important for investors?
A: Investors use this data to assess the profitability, efficiency, and potential growth of pharmaceutical companies and the broader healthcare sector.
Q: How often is this data updated?
A: The data is typically updated quarterly, reflecting the most recent financial reporting period for pharmaceutical corporations.
Q: What factors can influence this trend?
A: Factors include research and development costs, drug approvals, market competition, healthcare policy changes, and overall economic conditions.
Q: Can this trend predict future pharmaceutical sector performance?
A: While not a definitive predictor, the trend provides valuable insights into the sector's financial health and potential future performance.
Related News
Gen Z In the U.S. Shifts From Spending To Saving Habits
How Gen Z's Shift from Spending to Saving is Impacting the US Economy Recent trends indicate a significant shift in the spending habits of Gen Z, w...
U.S. Treasury Yields Decline After Inflation Data Meet Expectations
US Treasury Yields Drop as Inflation Data Meets Expectations US Treasury yields have seen a noticeable decline recently, as the latest inflation da...
S&P 500 Rises With Optimistic U.S. Inflation Report
S&P 500 Soars: Positive U.S. Inflation Developments The S&P 500, a primary stock index that tracks the performance of 500 major U.S. companies, has...
U.S. Stock Market Rises Amid PCE Inflation Report Analysis
U.S. Stock Market Climbs Amidst Insights from PCE Inflation Report Investors in the U.S. stock market are focusing on the most recent PCE Inflation...
U.S. GDP Growth to Slow Due to Tariffs and Immigration Policies
How Tariffs and Immigration Policies Influence U.S. GDP Growth in 2025 The U.S. GDP is a fundamental gauge of the country's economic health. Recent...
U.S. Stock Market Futures Rise On Inflation and Tariff News
US Stock Market Futures Rise Amid Inflation Data and Tariff News US stock market futures are on the rise, driven by significant updates in inflatio...
Related Trends
Quarterly Financial Report: U.S. Corporations: All Other Information: Depreciation, Depletion, and Amortization of Property, Plant, and Equipment
QFR102519USNO
Quarterly Financial Report: U.S. Corporations: Paper: Net Sales, Receipts, and Operating Revenues
QFR101322USNO
Quarterly Financial Report: U.S. Corporations: Electrical Equipment, Appliances, and Components: Interest Expense
QFR105335USNO
Quarterly Financial Report: U.S. Corporations: Food and Beverage Stores: Other Direct Credits (Charges) to Retained Earnings (Net)
QFRD122445USNO
Quarterly Financial Report: U.S. Corporations: Telecommunications: All Other Operating Costs and Expenses
QFR103517USNO
Quarterly Financial Report: U.S. Corporations: Management and Technical Consulting Services: Trade Accounts and Trade Notes Receivable (Less Allowance for Doubtful Accounts)
QFRD213546USNO
Citation
U.S. Federal Reserve, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Income (Loss) After Income Taxes [QFR115385USNO], retrieved from FRED.
Last Checked: 8/1/2025